The Exchange has sought clarification from Lupin Limited with respect to recent news item captioned Pharma stocks slump as Trump shoots letters to 17 global drug majors seeking lower prices. The response from the Company is awaited.

Regulatory & Legal

LUPIN · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

NSE has asked Lupin Limited to clarify a recent news report that caused pharma stocks to fall. The article mentioned Trump sending letters to 17 global drug companies seeking lower drug prices. Lupin's response to the exchange is still awaited. Until the company responds, the exact impact on Lupin's business remains unconfirmed by management.

Likely market impact

The stock may remain under short-term pressure until the company provides its clarification. Investors should wait for Lupin's official response to understand any direct business impact, if any.